Curium Pharma, a French maker of medical imaging supplies, and buyout firm H.I.G. Capital are among suitors shortlisted in the bidding for Cardinal Health Inc.’s nuclear medicine business, people familiar with the matter said.
To read the entire story, you must be logged in.
Please log in now or register with us.
